Leaflet DOCETAXEL ACTAVIS 20mg / ml concentrate for solution for infusion

Product code:
W55902002
Quantity:
1
Indicated for:
cancer
Route of administration:
infusion
Substance:
docetaxel (taxane antineoplastic)
ATC
L01CD02 — Antineoplastic and immunomodulating agents | Plant alkaloids and other natural products | Taxanes

Precautions:

Fertility warning

Fertility warning

This medicine may affect fertility.

Dose adjustment in hepatic impairment

Dose adjustment in hepatic impairment

Dose adjustment may be needed in liver disease.

Cytotoxic / special handling

Cytotoxic / special handling

Handle with special care.

Contraception required

Contraception required

Effective contraception is required during treatment.

Contraindicated during breastfeeding

Contraindicated during breastfeeding

Do not use this medicine while breastfeeding.

Contraindicated during pregnancy

Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hepatotoxicity

Hepatotoxicity

This medicine may affect the liver.

Major drug interactions

Major drug interactions

This medicine may have important interactions with other medicines.

Myelosuppression / agranulocytosis

Myelosuppression / agranulocytosis

This medicine may lower blood cell counts.

Additional monitoring

Additional monitoring

This medicine is subject to additional monitoring.

Requires periodic laboratory tests

Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Severe skin reactions

Severe skin reactions

Stop taking the medicine and seek urgent medical help if a severe rash occurs.

Docetaxel is a chemotherapy drug used for the treatment of various types of cancer, including breast cancer, lung cancer, and prostate cancer. It belongs to the taxane class and works by inhibiting cell division, preventing the growth and spread of cancer cells.

The medication is administered intravenously, usually as part of a specific regimen, under the supervision of an oncologist. It is effective in reducing tumor size and prolonging patient survival.

Side effects may include nausea, vomiting, hair loss, neutropenia, and, in rare cases, severe allergic reactions. Close monitoring is essential during treatment.

Consult your doctor to discuss the benefits and risks of treatment with Docetaxel. This medication must be administered exclusively in controlled environments, such as hospitals.

General data about DOCETAXEL ACTAVIS 20mg / ml

Substance:
docetaxel
Date of latest medicines list:
01-06-2026
Product code:
W55902002
Concentration:
20mg / ml
Pharmaceutical form:
concentrate for solution for infusion
Quantity:
1
Product type:
Generic medicine
Price:
252.07 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
SINDAN - PHARMA S.R.L. - ROMANIA
Holder:
TEVA PHARMACEUTICAL S.R.L. - ROMANIA
Number:
11654/2019/01
Shelf life:
2 years-after packing for marketing;after the first opening of the bottle-it is used immediately

Concentrations available for docetaxel

  • 10mg/ml
  • 120mg/6ml
  • 160mg/8ml
  • 20mg
  • 20mg/0.5ml
  • 20mg/1ml
  • 20mg/ml
  • 40mg/ml
  • 80mg
  • 80mg/2ml
  • 80mg/4ml

Compensation lists for DOCETAXEL ACTAVIS 20mg / ml Actavis

NHP 3 (C2) - NHP oncology

Price
252.07 RON
Copayment
250.43 RON
Patient
1.64 RON